These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36424703)

  • 21. Evaluation of cervical conization as a definitive treatment for microinvasive cervical carcinoma and cervical intraepithelial neoplasia grade 3.
    Takeda N; Suzuki T; Suzuki M; Matsuura M; Tanaka R; Fujii M; Ito E; Saito T
    Arch Gynecol Obstet; 2012 Feb; 285(2):453-7. PubMed ID: 21681515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and risk factors for residual cervical neoplasia in subsequent hysterectomy following LEEP or conization.
    Natee J; Therasakvichaya S; Boriboonhirunsarn D
    J Med Assoc Thai; 2005 Oct; 88(10):1344-8. PubMed ID: 16519377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repeat surgery in patients with cervical cancer stage FIGO IA1: a series of 156 cases and a review of the literature.
    Hefler LA; Polterauer S; Schneitter A; Concin N; Hofstetter G; Bentz E; Leipold H; Tempfer C; Reinthaller A
    Anticancer Res; 2010 Feb; 30(2):565-8. PubMed ID: 20332471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncologic and obstetric outcomes after conization for adenocarcinoma in situ or stage IA1 cervical cancer.
    Wang X; Bi Y; Wu H; Wu M; Li L
    Sci Rep; 2020 Nov; 10(1):19920. PubMed ID: 33199765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cervical conization of adenocarcinoma in situ: a predicting model of residual disease.
    Tierney KE; Lin PS; Amezcua C; Matsuo K; Ye W; Felix JC; Roman LD
    Am J Obstet Gynecol; 2014 Apr; 210(4):366.e1-366.e5. PubMed ID: 24370689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenocarcinoma in situ of the uterine cervix: a metaanalysis of 1278 patients evaluating the predictive value of conization margin status.
    Salani R; Puri I; Bristow RE
    Am J Obstet Gynecol; 2009 Feb; 200(2):182.e1-5. PubMed ID: 19019325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenocarcinoma in situ of the uterine cervix.
    Muntz HG; Bell DA; Lage JM; Goff BA; Feldman S; Rice LW
    Obstet Gynecol; 1992 Dec; 80(6):935-9. PubMed ID: 1448263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical outcome and high risk factor for residual lesion analysis of HSIL half a year after loop electrosurgical excision procedure: a clinical study of 1 502 cases].
    Liu L; Chen LM; Tao X; Dai F; Guo LP; Zhang HW; Zhou XR; Sui L
    Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):751-756. PubMed ID: 29179270
    [No Abstract]   [Full Text] [Related]  

  • 29. Predictive factors used to justify hysterectomy after loop conization: increasing age and severity of disease.
    Kalogirou D; Antoniou G; Karakitsos P; Botsis D; Kalogirou O; Giannikos L
    Eur J Gynaecol Oncol; 1997; 18(2):113-6. PubMed ID: 9105859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Cold-Knife Conization versus Loop Electrosurgical Excision for Cervical Adenocarcinoma In Situ (ACIS): A Systematic Review and Meta-Analysis.
    Jiang Y; Chen C; Li L
    PLoS One; 2017; 12(1):e0170587. PubMed ID: 28125627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Value of endocervical margin and high-risk human papillomavirus status after conization for high-grade cervical intraepithelial neoplasia, adenocarcinoma in situ, and microinvasive carcinoma of the uterine cervix.
    Kong TW; Son JH; Chang SJ; Paek J; Lee Y; Ryu HS
    Gynecol Oncol; 2014 Dec; 135(3):468-73. PubMed ID: 25284039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix.
    Poynor EA; Barakat RR; Hoskins WJ
    Gynecol Oncol; 1995 May; 57(2):158-64. PubMed ID: 7729727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of recurrence following laparoscopic radical hysterectomy for early-stage cervical cancer: A multi-institutional study.
    Casarin J; Buda A; Bogani G; Fanfani F; Papadia A; Ceccaroni M; Malzoni M; Pellegrino A; Ferrari F; Greggi S; Uccella S; Pinelli C; Cromi A; Ditto A; Di Martino G; Anchora LP; Falcone F; Bonfiglio F; Odicino F; Mueller M; Scambia G; Raspagliesi F; Landoni F; Ghezzi F
    Gynecol Oncol; 2020 Oct; 159(1):164-170. PubMed ID: 32665147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of persistent or recurrent neoplasia in conservatively treated women with cervical adenocarcinoma in situ with negative histological margins.
    Munro A; Codde J; Spilsbury K; Stewart CJ; Steel N; Leung Y; Tan J; Salfinger SG; Mohan GR; Semmens JB; Cohen PA
    Acta Obstet Gynecol Scand; 2017 Apr; 96(4):432-437. PubMed ID: 28181670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathologic features of early adenocarcinoma of the cervix initially managed with cervical conization.
    Poynor EA; Marshall D; Sonoda Y; Slomovitz BM; Barakat RR; Soslow RA
    Gynecol Oncol; 2006 Dec; 103(3):960-5. PubMed ID: 16860853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incomplete excision of cervical intraepithelial neoplasia as a predictor of the risk of recurrent disease-a 16-year follow-up study.
    Alder S; Megyessi D; Sundström K; Östensson E; Mints M; Belkić K; Arbyn M; Andersson S
    Am J Obstet Gynecol; 2020 Feb; 222(2):172.e1-172.e12. PubMed ID: 31473226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term follow-up results from women with cervical adenocarcinoma in situ treated by conization: an experience from a large academic women's hospital.
    Li Z; Zhao C
    J Low Genit Tract Dis; 2013 Oct; 17(4):452-8. PubMed ID: 23903202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Menopausal status is associated with a high risk for residual disease after cervical conization with positive margins.
    Bilibio JP; Monego HI; Binda MLA; Dos Reis R
    PLoS One; 2019; 14(6):e0217562. PubMed ID: 31163055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conization using the Shimodaira-Taniguchi procedure for adenocarcinoma in situ of the uterine cervix.
    Hiramatsu K; Ueda Y; Yoshino K; Fujita M; Morii E; Enomoto T; Kimura T
    Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):218-21. PubMed ID: 23395556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases.
    Ostör AG; Duncan A; Quinn M; Rome R
    Gynecol Oncol; 2000 Nov; 79(2):207-10. PubMed ID: 11063645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.